Related Experiment Video
Updated: Feb 7, 2026

A Porcine Corneal Endothelial Organ Culture Model Using Split Corneal Buttons
Published on: October 6, 2019
Fuchs Endothelial Corneal Dystrophy: Update on Pathogenesis and Future Directions
Caterina Sarnicola1, Asim V Farooq, Kathryn Colby
1Department of Biomedical and Specialty Surgical Sciences, Section of Ophthalmology (C.S.), University of Ferrara, Ferrara, Italy; and Department of Ophthalmology and Visual Science (C.S., A.V.F., K.C.), University of Chicago, Chicago, IL.
Fuchs endothelial corneal dystrophy (FECD) is a leading cause of corneal transplants. Research is advancing our understanding of FECD biology and potential treatments, drawing parallels with neurodegenerative diseases.
Area of Science:
- Ophthalmology
- Genetics
- Neuroscience
Background:
- Fuchs endothelial corneal dystrophy (FECD) is the most common reason for corneal transplantation in the US.
- Corneal transplantation rates for FECD are significant, with 36% of nearly 47,000 transplants in 2016 attributed to this condition.
- Despite advancements in surgical management, the underlying pathogenesis of FECD remains unclear, with numerous proposed pathways and candidate genes.
Purpose of the Study:
- To review recent progress in understanding the biology of FECD.
- To explore potential connections between FECD and neurodegenerative diseases, such as amyotrophic lateral sclerosis.
- To highlight future directions for FECD treatment.
Main Methods:
- Literature review of recent advancements in FECD research.
- Analysis of genetic and biological pathways implicated in FECD.
- Comparative study of FECD pathogenesis with neurodegenerative disorders.
Main Results:
- Multiple candidate genes and disease pathways are being investigated for their role in FECD.
- Potential biological similarities exist between FECD and neurodegenerative conditions.
- Current research is paving the way for novel therapeutic strategies.
Conclusions:
- Understanding FECD pathogenesis is crucial for developing targeted treatments.
- Investigating parallels with neurodegenerative diseases may offer new insights into FECD.
- Future research holds promise for improved therapeutic interventions for FECD patients.
Related Concept Videos
Pulmonary Hypertension: Classification and Pathogenesis
There are various classifications for PH, each relating to different underlying causes and also...
Satellite Stem Cells and Muscular Dystrophy
Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Directing Effect of Substituents: meta-Directing Groups

